CME Group Inc.

NasdaqGS:CME Stock Report

Market Cap: US$95.7b

CME Group Valuation

Is CME undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CME when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
US$234.86
Fair Value
11.3% overvalued intrinsic discount
17
Number of Analysts

Below Fair Value: CME ($261.48) is trading above our estimate of fair value ($234.86)

Significantly Below Fair Value: CME is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CME?

Key metric: As CME is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for CME. This is calculated by dividing CME's market cap by their current earnings.
What is CME's PE Ratio?
PE Ratio26.3x
EarningsUS$3.58b
Market CapUS$95.70b

Price to Earnings Ratio vs Peers

How does CME's PE Ratio compare to its peers?

The above table shows the PE ratio for CME vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average36.2x
ICE Intercontinental Exchange
33.6x8.9%US$92.3b
MCO Moody's
36.8x10.0%US$77.3b
SPGI S&P Global
38.3x10.3%US$146.4b
MSCI MSCI
36.1x10.3%US$41.7b
CME CME Group
26.3x4.4%US$95.7b

Price-To-Earnings vs Peers: CME is good value based on its Price-To-Earnings Ratio (26.3x) compared to the peer average (36.2x).

Price to Earnings Ratio vs Industry

How does CME's PE Ratio compare vs other companies in the US Capital Markets Industry?

21 CompaniesPrice / EarningsEstimated GrowthMarket Cap
ADX Adams Diversified Equity Fund
4xn/aUS$2.13b
CET Central Securities
4.3xn/aUS$1.23b
GAM General American Investors Company
4.9xn/aUS$1.14b
ASA ASA Gold and Precious Metals
4.9xn/aUS$577.88m
CME 26.3xIndustry Avg. 23.9xNo. of Companies72PE020406080100+
21 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: CME is expensive based on its Price-To-Earnings Ratio (26.3x) compared to the US Capital Markets industry average (23.9x).

Price to Earnings Ratio vs Fair Ratio

What is CME's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CME PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio26.3x
Fair PE Ratio16.8x

Price-To-Earnings vs Fair Ratio: CME is expensive based on its Price-To-Earnings Ratio (26.3x) compared to the estimated Fair Price-To-Earnings Ratio (16.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CME forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$261.48
US$268.76
+2.8%
8.8%US$301.00US$219.00n/a17
Apr ’26US$262.24
US$257.65
-1.8%
9.0%US$290.00US$200.00n/a17
Mar ’26US$253.77
US$254.63
+0.3%
8.8%US$290.00US$200.00n/a16
Feb ’26US$236.52
US$243.19
+2.8%
8.8%US$275.00US$190.00n/a16
Jan ’26US$232.23
US$242.38
+4.4%
8.7%US$275.00US$192.00n/a16
Dec ’25US$238.00
US$236.00
-0.8%
9.0%US$275.00US$181.00n/a16
Nov ’25US$223.61
US$235.31
+5.2%
9.3%US$275.00US$181.00n/a16
Oct ’25US$225.28
US$218.00
-3.2%
8.9%US$250.00US$177.00n/a16
Sep ’25US$215.74
US$218.50
+1.3%
8.0%US$250.00US$191.00n/a14
Aug ’25US$196.31
US$218.00
+11.0%
8.3%US$250.00US$191.00n/a14
Jul ’25US$195.50
US$223.80
+14.5%
9.5%US$250.00US$187.00n/a15
Jun ’25US$202.98
US$225.93
+11.3%
8.1%US$250.00US$187.00n/a15
May ’25US$208.07
US$226.27
+8.7%
8.0%US$250.00US$187.00n/a15
Apr ’25US$212.02
US$225.60
+6.4%
8.9%US$250.00US$185.00US$262.2415
Mar ’25US$219.21
US$225.67
+2.9%
8.8%US$250.00US$185.00US$253.7715
Feb ’25US$205.79
US$221.87
+7.8%
9.5%US$250.00US$180.00US$236.5215
Jan ’25US$210.60
US$228.01
+8.3%
8.4%US$250.00US$180.00US$232.2315
Dec ’24US$219.54
US$227.53
+3.6%
8.5%US$250.00US$180.00US$238.0015
Nov ’24US$210.92
US$227.40
+7.8%
8.5%US$250.00US$180.00US$223.6115
Oct ’24US$200.22
US$213.25
+6.5%
8.6%US$250.00US$173.00US$225.2814
Sep ’24US$202.89
US$210.50
+3.8%
10.4%US$250.00US$167.00US$215.7414
Aug ’24US$199.83
US$213.44
+6.8%
10.8%US$254.00US$167.00US$196.3116
Jul ’24US$185.29
US$206.47
+11.4%
11.0%US$250.00US$160.00US$195.5015
Jun ’24US$180.02
US$205.43
+14.1%
11.5%US$250.00US$160.00US$202.9814
May ’24US$186.63
US$205.86
+10.3%
11.4%US$250.00US$160.00US$208.0714
Apr ’24US$191.52
US$205.75
+7.4%
11.0%US$250.00US$160.00US$212.0216
AnalystConsensusTarget
Consensus Narrative from 17 Analysts
US$268.76
Fair Value
2.7% undervalued intrinsic discount
17
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/23 03:42
End of Day Share Price 2025/04/23 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CME Group Inc. is covered by 38 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stephen BiggarArgus Research Company
Benjamin BudishBarclays
Roger FreemanBarclays